GAMCO Investors’s Vigil Neuroscience VIGL Stock Holding History

GAMCO Investors’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-75,000	Closed	-$596K	–	1072
2025 Q2	$596K	Buy	+75,000	New	+$336K	0.01%	781

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

GAMCO Investors's VIGL Position: Q3 2025 in Review

GAMCO Investors sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 75,000 shares — an estimated $596K sold.

GAMCO Investors first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $596K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

GAMCO Investors reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
GAMCO Investors sold 75,000 Vigil Neuroscience shares in Q3 2025, an estimated $596K.
GAMCO Investors first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
GAMCO Investors's Vigil Neuroscience position peaked at $596K in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on GAMCO Investors's 13F filing for Q3 2025, filed 12 Nov 2025.